Retrospective analysis of renal prognosis in elderly coronary artery disease patients complicated with renal insufficiency

Aging (Albany NY). 2021 Oct 4;13(19):22856-22866. doi: 10.18632/aging.203579. Epub 2021 Oct 4.

Abstract

Objective and methods: The aim of this study was to retrospectively analyze the renal prognosis of elderly coronary artery disease (CAD) patients complicated with renal insufficiency.

Results: A total of 307 patients were included. The mean follow-up period was 25±11months. The average age was 79±7 years. In the worsening renal function group, there were higher occurrence rate of heart failure and severe coronary artery stenosis, lower rate of percutaneous coronary intervention, lower medication rate of renin-angiotensin blocker, lower plasma albumin, magnesium and hemoglobulin level. There was no significant difference in the rate of worsening renal function or gastrointestinal bleeding between patients who took anti-platelet agents/statins and those without. Patients with reduced left ventricular ejective fraction had higher rate of worsening renal function, yet lower medication rate of renin-angiotensin blockers, lower plasma albumin and hemoglobulin level. Anemia, malnutrition and worsening cardiac function were risk factors of renal function deterioration and mortality.

Conclusions: In the elderly coronary artery disease patients who had renal insufficiency, antiplatelet agents and statin have non-adverse effects on renal function; lower medication rate of renin-angiotensin blocker were found in patients with either worsening renal function or heart failure. Anemia, malnutrition and worsening cardiac function are risk factors of renal function deterioration and mortality.

Keywords: coronary artery disease; elderly patients; renal insufficiency; renal prognosis; retrospective analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Coronary Disease / complications*
  • Coronary Disease / drug therapy
  • Diabetes Mellitus
  • Female
  • Humans
  • Hypertension / complications
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use
  • Renal Insufficiency / complications*
  • Renal Insufficiency / pathology*
  • Retrospective Studies
  • Risk Factors

Substances

  • Platelet Aggregation Inhibitors